Patents by Inventor Ta-Hsiang Chao
Ta-Hsiang Chao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220328312Abstract: A method for manufacturing semiconductor elements by a metal lift-off process and a semiconductor element manufactured thereby, include steps of photoresist-coating, exposing, developing, metal-coating, and lift-off. A photoresist layer can be removed with a photoresist stripper. Meanwhile, the metal on the top of the photoresist layer can also be removed when the photoresist layer is removed. The circuit layout required for the semiconductor element can thus be completed without an etching process. In addition, by setting the process parameters, the contour of the photoresist layer can present a certain angle, so that the metal on the surface of the photoresist layer can be completely removed, which saves costs and improves competitiveness.Type: ApplicationFiled: August 13, 2021Publication date: October 13, 2022Inventors: Cheng-Hsing Tsou, Ta-Hsiang Chao, Jung-Sen Hu
-
Publication number: 20160195652Abstract: A method of manufacturing an optical filtering element includes a preparing step and a layer-forming step. The preparing step comprises preparing a glass material, a red light absorbing material composed of a medium and an organic pigment, and an infrared reflective-layer material composed by two or more materials with different reflectivities stacked with each other. The glass material is cut to form multiple glass substrates. The red light absorbing material is coated on the glass substrates and is heated at 300° C. to form a red light absorbing layer on each glass substrate. The infrared reflective-layer material is coated on the glass substrates to form multiple infrared light reflective layers on each glass substrate.Type: ApplicationFiled: June 2, 2014Publication date: July 7, 2016Applicant: Opto Optics Corp.Inventors: Ta-Hsiang Chao, Shih-Hsuan Lin
-
Patent number: 8389564Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.Type: GrantFiled: May 14, 2012Date of Patent: March 5, 2013Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
-
Publication number: 20120270919Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.Type: ApplicationFiled: May 14, 2012Publication date: October 25, 2012Applicant: Nereus Pharmaceuticals, Inc.Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
-
Publication number: 20120238634Abstract: Described herein are chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. Also described are methods of synthesizing natural products and novel, structurally-related chemical compounds. More particularly, disclosed are new analogs of and processes for the preparation of compounds and pharmaceutical compositions thereof useful in the treatment of, for example, inflammation, cancer, multiple myeloma, cachexia, cardiovascular disease, anti-infectious, diabetes, otitis media, sinusitis and transplant rejection.Type: ApplicationFiled: March 9, 2012Publication date: September 20, 2012Applicant: NEREUS PHARMACEUTICALS, INC.Inventors: Michael A. Palladino, Emmanuel A. Theodorakis, Venkat Rami Reddy Macherla, Ta-Hsiang Chao, Young-Ger Suh
-
Patent number: 8227503Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.Type: GrantFiled: March 21, 2011Date of Patent: July 24, 2012Assignee: Nereus Pharmaceuticals, Inc.Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
-
Patent number: 8133915Abstract: Described herein are chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. Also described are methods of synthesizing natural products and novel, structurally-related chemical compounds. More particularly, disclosed are new analogs of and processes for the preparation of compounds and pharmaceutical compositions thereof useful in the treatment of, for example, inflammation, cancer, multiple myeloma, cachexia, cardiovascular disease, anti-infectious, diabetes, otitis media, sinusitis and transplant rejection.Type: GrantFiled: January 14, 2011Date of Patent: March 13, 2012Assignees: Nereus Pharmaceuticals, Inc., The Regents of the University of CaliforniaInventors: Michael A. Palladino, Emmanuel A. Theodorakis, Venkat Rami Reddy Macherla, Ta-Hsiang Chao, Young-Ger Suh
-
Publication number: 20110172285Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.Type: ApplicationFiled: March 21, 2011Publication date: July 14, 2011Applicant: NEREUS PHARMACEUTICALS, INC.Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
-
Publication number: 20110160309Abstract: Described herein are chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. Also described are methods of synthesizing natural products and novel, structurally-related chemical compounds. More particularly, disclosed are new analogs of and processes for the preparation of compounds and pharmaceutical compositions thereof useful in the treatment of, for example, inflammation, cancer, multiple myeloma, cachexia, cardiovascular disease, anti-infectious, diabetes, otitis media, sinusitis and transplant rejection.Type: ApplicationFiled: January 14, 2011Publication date: June 30, 2011Applicant: Nereus Pharmaceuticals, Inc.Inventors: Michael A. Palladino, Emmanuel A. Theodorakis, Venkat Rami Reddy Macherla, Ta-Hsiang Chao, Young-Ger Suh
-
Patent number: 7910616Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.Type: GrantFiled: May 12, 2009Date of Patent: March 22, 2011Assignee: Nereus Pharmaceuticals, Inc.Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
-
Patent number: 7893299Abstract: Described herein are chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. Also described are methods of synthesizing natural products and novel, structurally-related chemical compounds. More particularly, disclosed are new analogs of and processes for the preparation of compounds and pharmaceutical compositions thereof useful in the treatment of, for example, inflammation, cancer, multiple myeloma, cachexia, cardiovascular disease, anti-infectious, diabetes, otitis media, sinusitis and transplant rejection.Type: GrantFiled: July 14, 2006Date of Patent: February 22, 2011Assignees: Nereus Pharmaceuticals, Inc., The Regents of the University of CaliforniaInventors: Michael A. Palladino, Emmanuel A. Theodorakis, Venkat Rami Reddy Macherla, Ta-Hsiang Chao, Young Ger Suh
-
Publication number: 20090298906Abstract: Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation.Type: ApplicationFiled: May 12, 2009Publication date: December 3, 2009Applicant: NEREUS PHARMACEUTICALS, INC.Inventors: Venkat Rami Reddy Macherla, Barbara Christine Potts, Rama Rao Manam, Katherine A. McArthur, Ta-Hsiang Chao, Saskia Theodora Cornelia Neuteboom
-
Patent number: 7544814Abstract: Compounds of Formulae I-VI and derivatives thereof having anti-cancer, anti-inflammatory, and anti-microbial properties and to compositions that include one or more of compounds and their derivatives or analogs having anti-cancer, anti-inflammatory and anti-microbial properties are disclosed. Pharmaceutical compositions comprising such compounds and methods of treating cancer, inflammatory conditions, and microbial infections with the disclosed compounds or the disclosed pharmaceutical compositions are also disclosed.Type: GrantFiled: October 1, 2007Date of Patent: June 9, 2009Assignee: Nereus Pharmaceuticals, Inc.Inventors: Barbara Christine Potts, Venkat Macherla, Scott Sherman Mitchell, Ram Rao Manam, Katherine A. McArthur, Kin Sing Lam, Saskia Neuteboom, Ta-Hsiang Chao, Benjamin Nicholson, Cheryl L. Billstrom
-
Publication number: 20080070969Abstract: Compounds of Formulae I-VI and derivatives thereof having anti-cancer, anti-inflammatory, and anti-microbial properties and to compositions that include one or more of compounds and their derivatives or analogs having anti-cancer, anti-inflammatory and anti-microbial properties are disclosed. Pharmaceutical compositions comprising such compounds and methods of treating cancer, inflammatory conditions, and microbial infections with the disclosed compounds or the disclosed pharmaceutical compositions are also disclosed.Type: ApplicationFiled: October 1, 2007Publication date: March 20, 2008Applicant: Nereus Pharmaceuticals, Inc.Inventors: Barbara Potts, Venkat Macherla, Scott Mitchell, Ram Manam, Katherine Reed, Kin Lam, Saskia Neuteboom, Ta-Hsiang Chao, Benjamin Nicholson, Cheryl Billstrom
-
Publication number: 20080064753Abstract: Described herein are chemical compounds and pharmaceutical compositions, including novel chemical compounds and pharmaceutical compositions thereof, useful in the treatment of various diseases and disease states. Also described are methods of synthesizing natural products and novel, structurally-related chemical compounds. More particularly, disclosed are new analogs of and processes for the preparation of compounds and pharmaceutical compositions thereof useful in the treatment of, for example, inflammation, cancer, multiple myeloma, cachexia, cardiovascular disease, anti-infectious, diabetes, otitis media, sinusitis and transplant rejection.Type: ApplicationFiled: July 14, 2006Publication date: March 13, 2008Inventors: Michael A. Palladino, Emmanuel A. Theodorakis, Venkat Rami Reddy Macherla, Ta-Hsiang Chao, Young Ger Suh
-
Patent number: 7276530Abstract: Compounds of Formulae I-VI and derivatives thereof having anti-cancer, anti-inflammatory, and anti-microbial properties and to compositions that include one or more of compounds and their derivatives or analogs having anti-cancer, anti-inflammatory and anti-microbial properties are disclosed. Pharmaceutical compositions comprising such compounds and methods of treating cancer, inflammatory conditions, and microbial infections with the disclosed compounds or the disclosed pharmaceutical compositions are also disclosed.Type: GrantFiled: April 29, 2005Date of Patent: October 2, 2007Assignee: Nereus Pharmaceuticals, Inc.Inventors: Barbara Christine Potts, Venkat Macherla, Scott Sherman Mitchell, Ram Rao Manam, Katherine Reed, Kin Sing Lam, Saskia Neuteboom, Ta-Hsiang Chao, Benjamin Nicholson, Cheryl Billstrom
-
Publication number: 20050288352Abstract: Compounds of Formulae I-VI and derivatives thereof having anti-cancer, anti-inflammatory, and anti-microbial properties and to compositions that include one or more of compounds and their derivatives or analogs having anti-cancer, anti-inflammatory and anti-microbial properties are disclosed. Pharmaceutical compositions comprising such compounds and methods of treating cancer, inflammatory conditions, and microbial infections with the disclosed compounds or the disclosed pharmaceutical compositions are also disclosed.Type: ApplicationFiled: April 29, 2005Publication date: December 29, 2005Inventors: Barbara Potts, Venkat Macherla, Scott Mitchell, Ram Manam, Katherine Reed, Kin Lam, Saskia Neuteboom, Ta-Hsiang Chao, Benjamin Nicholson, Cheryl Billstrom